Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Leukemia, Myeloid, Acute 100Lymphoma, Non-Hodgkin 90Leukemia, Lymphocytic, Chronic, B-Cell 85Hodgkin Disease 84Myelodysplastic Syndromes 83Multiple Myeloma 69Leukemia 66Lymphoma, Mantle-Cell 63Lymphoma 63Lymphoma, Follicular 59Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelogenous, Chronic, BCR-ABL Positive 52Burkitt Lymphoma 50Lymphoma, Large B-Cell, Diffuse 49Myeloproliferative Disorders 48Leukemia, Myelomonocytic, Chronic 41Lymphoma, Large-Cell, Immunoblastic 36Waldenstrom Macroglobulinemia 33Leukemia, Myeloid, Accelerated Phase 32Primary Myelofibrosis 30Leukemia, Myeloid, Chronic-Phase 30Congenital Abnormalities 29Lymphoma, Large-Cell, Anaplastic 28Lymphoma, T-Cell, Cutaneous 27Leukemia, Biphenotypic, Acute 27Dendritic Cell Sarcoma, Interdigitating 26Anemia, Refractory, with Excess of Blasts 26Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Blast Crisis 25

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 5Ciprofloxacin 4gamma-Globulins 3Voriconazole 3Caspofungin 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Levofloxacin 2Itraconazole 2Immunoglobulins, Intravenous 2Fluconazole 2fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Whole-Body Irradiation × Lymphoid × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡